Moderna, Inc. vs Match Group Inc — how do they compare? Moderna, Inc. trades at $60.83 (market cap $23.88B), while Match Group Inc trades at $36.82 (market cap $8.43B). The key difference: Moderna, Inc. is far larger — about 2.8× Match Group Inc's market cap, and Match Group Inc pays a 2.18% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.
| MRNA | MTCH | |
|---|---|---|
Market Cap | $23.88B | $8.43B |
Sector | Health | Media |
52-Week High | $81.80 | $41.24 |
52-Week Low | $22.36 | $28.90 |
Enterprise Value | $20.03B | $11.40B |
Dividend Yield | — | 2.18% |
Trailing returns across standard periods
Latest headlines on both assets
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →Match Group is a provider of online dating products. The firm became public in 2015 and was more than 80% owned by IAC/InterActiveCorp until IAC spun it off in the second quarter of 2020. The company has a vast portfolio of different online dating service providers, including Tinder, Match.com, OkCupid, Plenty of Fish, and Meetic. Match Group has more than 45 brands of online dating sites and/or apps, from which it generates user fee revenue (95%) and advertising revenue (5%).
Read more on MTCH →